增强CT对O-RADS US 4/5类上皮性卵巢肿瘤的再分层价值
回顾性纳入210例经病理证实的上皮性卵巢肿瘤患者,共258个附件病灶,比较增强CT在超声O-RADS 4/5分类基础上的再分层能力。结果显示,病灶层面增强CT总体预测准确率为88.8%,O-RADS 4类为87.5%,O-RADS 5类为90.0%。作者认为增强CT可提供附加诊断价值,有助于个体化手术规划。
要点
- 超声O-RADS 4/5高危病灶中,增强CT再分层总准确率接近90%。
- 排除良性病变后,患者层面增强CT准确率89.3%,高于超声的72.0%。
- 增强CT形态与强化特征可辅助区分交界性肿瘤与浸润性癌。
核心结论
- 增强CT对超声O-RADS 4或5类上皮性卵巢肿瘤具有附加诊断价值,有助于病灶定性和个体化手术规划。
研究设计与样本
- 共分析210例女性,平均年龄48.2±14.2岁,共258个附件病灶。
- 依据基于O-RADS词典的CT形态与强化特征,将病灶分为良性、交界性和恶性三类。
关键影像表现/征象
- 增强CT形态与强化特征可对上皮性卵巢肿瘤进行良性、交界性、恶性分类。
诊断标准与关键数值
- 病灶层面增强CT总体预测准确率为88.8%(229/258;95%CI:84.3%-92.1%)。
- 超声O-RADS 4类病灶中,增强CT准确率为87.5%(95%CI:80.7%-92.2%)。
- 超声O-RADS 5类病灶中,增强CT准确率为90.0%(117/130;95%CI:83.6%-94.1%)。
- 排除良性上皮性卵巢肿瘤患者后,患者层面增强CT诊断准确率为89.3%(95%CI:84.0%-92.9%),超声为72.0%(95%CI:65.2%-78.0%)。
- 采用Cohen κ评估读者间一致性,采用McNemar检验比较增强CT与超声区分交界性肿瘤和浸润性癌的诊断效能。
临床应用与阅片要点
- 对超声O-RADS 4/5类附件病变,增强CT可作为再分层工具,辅助优化手术策略。
- 增强CT的形态与强化特征可用于对附件病变进行良性、交界性、恶性分类。
局限性
- 回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the diagnostic performance of contrast-enhanced CT (CE-CT) in restratifying epithelial ovarian tumors (EOTs) among high-risk patients categorized as Ovarian-Adnexal Reporting and Data System (O-RADS) 4 or 5 on ultrasound (US).
METHODS: This retrospective study included patients with pathologically confirmed EOTs who underwent preoperative transvaginal US and abdominopelvic CE-CT between September 2017 and December 2022. Lesions were classified into benign, borderline, or malignant categories according to O-RADS lexicon-based CT morphologic and enhancement features. Diagnostic performance parameters, including sensitivity, specificity, positive predictive value, negative predictive value, and accuracy, were calculated on both patient and lesion levels, and interreader agreement was assessed using Cohen's κ. The McNemar's test with continuity correction was used to compare the diagnostic performance of CE-CT and US for discriminating between borderline ovarian tumors and invasive carcinomas after excluding patients with benign EOTs.
RESULTS: A total of 210 women (mean age, 48.2 ± 14.2 years) with 258 adnexal lesions were analyzed. At the lesion level, the overall predictive accuracy of CE-CT was 88.8% (229 of 258; 95% confidence interval [CI]: 84.3%-92.1%). Among O-RADS 4 and 5 lesions, CE-CT demonstrated an accuracy of 87.5% (95% CI: 80.7%-92.2%) and 90.0% (117 of 130; 95% CI: 83.6%-94.1%), respectively. At the patient level, CE-CT achieved higher diagnostic accuracy than US (89.3%; 95% CI: 84.0%-92.9% versus 72.0%; 95% CI: 65.2%-78.0%) when excluding patients with benign EOTs.
CONCLUSION: CE-CT provides added diagnostic value in restratifying patients with EOTs who are categorized as O-RADS 4 or 5, aiding in characterizing adnexal lesions and supporting more individualized surgical planning.
引用
- Yang, Liu, Su, et al. Added Value of Contrast-Enhanced CT for Risk Stratification of Patients With Epithelial Ovarian Tumors Categorized as O-RADS US 4 and 5. J Am Coll Radiol. 2026. PMID: 42575404. doi:10.1016/j.jacr.2026.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。